Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.19.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Revenue    
Product revenue, net $ 23,376 $ 15,520
Revenue – from a related party 3,506 1,725
Net revenue 26,882 17,245
Operating expenses    
Cost of goods sold – product revenue 6,125 3,658
Research and development 83,333 48,322
Research and development – licenses acquired 4,050 4,164
General and administrative 53,371 50,897
Total operating expenses 146,879 107,041
Loss from operations (119,997) (89,796)
Other income (expenses)    
Interest income 1,104 819
Interest expense and financing fee (10,340) (7,687)
Change in fair value of derivative liabilities (682) (368)
Change in fair value of subsidiary convertible note 437 (457)
Change in fair value of investments (1,390) 226
Other income (loss) 68 (250)
Total other expenses (10,803) (7,717)
Loss from continuing operations (130,800) (97,513)
Discontinued operations:    
Gain from disposal of National 2,333 0
Loss from discontinued operations, net of tax (13,469) (2,323)
Total loss from discontinued operations (11,136) (2,323)
Net loss (141,936) (99,836)
Less: net loss attributable to non-controlling interests 57,789 32,960
Net loss attributable to common stockholders $ (84,147) $ (66,876)
Loss from continuing operations per common share – basic and diluted $ (3.01) $ (2.34)
Loss from discontinued operations per common share – basic and diluted (0.26) (0.06)
Net loss per common share attributable to common stockholders – basic and diluted $ (1.94) $ (1.61)
Weighted average common shares outstanding – basic and diluted 43,461,978 41,658,733